Dantrolene, A Treatment for Alzheimer Disease?

Dantrolene, A Treatment for Alzheimer Disease?
Alzheimer Dis Assoc Disord. 2014 Dec 30;
Authors: Liang L, Wei H
Abstract
Alzheimer disease (AD) is a fatal progressive disease and the most common form of dementia without effective treatments. Previous studies support that the disruption of endoplasmic reticulum Ca through overactivation of ryanodine receptors plays an important role in the pathogenesis of AD. Normalization of intracellular Ca homeostasis could be an effective strategy for AD therapies. Dantrolene, an antagonist of ryanodine receptors and an FDA-approved drug for clinical treatment of malignant hyperthermia and muscle spasms, exhibits neuroprotective effects in multiple models of neurodegenerative disorders. Recent preclinical studies consistently support the therapeutic effects of dantrolene in various types of AD animal models and were summarized in the current review.
PMID: 25551862 [PubMed - as supplied by publisher]

Source: Alzheimer Disease and Associated Disorders - January 4, 2015 Category: Psychiatry Tags: Alzheimer Dis Assoc Disord Source Type: research